Natco Pharma shares dive 29% in just 2 days; is it time to enter or there's more pain ahead?
The stock plunged 10.80 per cent to hit a 52-week low of Rs 868.25. At this price, it has tumbled 28.63 per cent in two ...
Aveng reports project challenges and forecasts losses for its 2024 year
The group, which operates the McConnell Dowell infrastructure construction engineering group in Australia, New Zealand, and ...